Among these, GHK-Cu (Copper Tripeptide-1) has become a widely discussed peptide due to its versatility across topical, cosmetic, and combination formulations.
At Wells Pharmacy Network, we support providers with a curated range of GHK-Cu compounded formulations, while also closely monitoring emerging peptides under regulatory review.
What is GHK-Cu?
GHK-Cu is a copper-binding tripeptide that has been explored in dermatology and aesthetic settings. It is often incorporated into compounded preparations intended to support skin appearance, texture, and overall skin appearance as part of provider-directed treatment protocols.
As interest in peptide-based strategies continues to evolve, GHK-Cu is frequently included in customized formulations designed for:
- Skin appearance support
- Texture and tone refinement
- Hydration-focused protocols
- Scalp and hair-related applications
All compounded preparations are prepared pursuant to a valid prescription and intended for individualized patient care.
Why Dermatology Practices Are Exploring GHK-Cu
One of the characteristics of GHK-Cu in compounding is its formulation flexibility.
Providers can explore GHK-Cu across multiple delivery formats and combination approaches, allowing for tailored protocol development.
This formulation flexibility may allow for:
- Personalized dermatology approaches
- Integration into provider-directed aesthetic treatment plans
- A range of peptide-based offerings
- Alignment with patient-specific preferences
GHK-Cu Formulations at Wells Pharmacy Network
Wells Pharmacy Network currently compounds a focused selection of active GHK-Cu-based formulations to support dermatology, aesthetics, and wellness-focused practices.
Topical & Facial Formulations
- GHK-Cu Copper Peptide (Facial) Cream – 1%
- GHK-Cu Copper Peptide (Facial) Cream – 2.5%
- GHK-Cu Copper Peptide + Niacinamide (Facial) Cream (0.5% / 4%)
- “NEW” GHK-Cu Copper Peptide (Facial) Luxurious Serum – 0.2% (Liquid/dropper)
Hair & Scalp-Focused Formulations
- Finasteride / GHK-Cu Foaming Pump
- Melafeine Hair Serum (Melatonin / Caffeine / GHK-Cu)
Alternative Delivery Formats
- GHK-Cu Copper Peptide (Foaming Pump) – 0.5%
- GHK-Cu Copper Peptide (Spray) Solution – 0.5%
Combination Peptide Formulations
- Arginine / Urea / GHK-Cu Foam
- GHK-Cu + HA (Revive Copper Tripeptide) Gel
- GHK-Cu + HA (Vaginal Copper Tripeptide) Gel
- Zinc-Thymulin / GHK-Cu Topical Spray
These options allow providers to explore customized peptide-based protocols aligned with patient-specific needs.
The Role of Customization in Dermatology
Compounding allows dermatology providers to explore customized approaches aligned with patient-specific goals.
With GHK-Cu, this includes:
- Selection of strength and concentration
- Combination with complementary ingredients
- Choice of delivery format (cream, gel, foam, spray)
- Integration into broader treatment strategies
Wells Pharmacy Network supports this process through responsive pharmacy collaboration and formulation flexibility pursuant to valid prescriptions.
Looking Ahead: Peptide-Based Options
GHK-Cu represents just one part of a growing category of peptide-based formulations in dermatology and aesthetics.
As regulatory frameworks evolve, additional peptide-based options may become available for compounding in accordance with FDA guidance¹.
Wells Pharmacy Network remains focused on responsible expansion of its peptide compounding formulations in alignment with regulatory standards.
Partner With Wells Pharmacy Network
As peptide-based formulations continue to gain attention, providers may value a compounding partner that supports flexibility, compliance, and responsive service.
Wells Pharmacy Network works alongside providers to develop personalized compounding formulations aligned with individual patient needs.
Connect with our team to learn more about GHK-Cu formulations and ongoing peptide developments.
References
- U.S. Food and Drug Administration.
Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act
https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act - U.S. Food and Drug Administration.
Compounding and the FDA: Questions and Answers
https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers - U.S. Food and Drug Administration.
Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A
https://www.fda.gov/media/98964/download
